The Human Gut Bacterial Genotoxin Colibactin Alkylates DNA

Wilson, Matthew R., Jiang, Yindi, Villalta, Peter W., Stornetta, Alessia, Boudreau, Paul D., Carrá, Andrea, Brennan, Caitlin A., Chun, Eunyoung +6 more·2019·Science
DOI 10.1126/science.aar7785

Cited by (635)

Items 401–500 of 635

  1. Cyclomodulins and Hemolysis in E. coli as Potential Low-Cost Non-Invasive Biomarkers for Colorectal Cancer Screening
    Kristýna Mezerová, Lubomír Starý, Pavel Zbořil, I Klementa, Martin Stašek, Petr Špička, Pavel Skalický, Vladislav Raclavský · 2021 · Life
  2. Advancing the Biosynthetic and Chemical Understanding of the Carcinogenic Risk Factor Colibactin and Its Producers
    Yuichiro Hirayama, Michio Sato, Kenji Watanabe · 2022 · Biochemistry
  3. Role of Bacteria in the Development of Colorectal Cancer
    Ryan Michael Thomas · 2023 · Clinics in Colon and Rectal Surgery
  4. Colibactin leads to a bacteria-specific mutation pattern and self-inflicted DNA damage
    Emily Lowry, Yiqing Wang, Tal Dagan, Amir Mitchell · 2024 · Genome Research
  5. The Anti- and Pro-Tumorigenic Role of Microbiota and Its Role in Anticancer Therapeutic Strategies
    Giulia Greco, Sabrina Donati Zeppa, Deborah Agostini, Giuseppe Attisani, Claudio Stefanelli, Fabio Ferrini, Piero Sestili, Carmela Fimognari · 2022 · Cancers
  6. Multi-adductomics: Advancing mass spectrometry techniques for comprehensive exposome characterization
    Mu‐Rong Chao, Yuan-Jhe Chang, Marcus S. Cooke, Chiung‐Wen Hu · 2024 · TrAC Trends in Analytical Chemistry
  7. Inverse Correlation between pks-Carrying Escherichia coli Abundance in Colorectal Cancer Liver Metastases and the Number of Organs Involved in Recurrence
    Yasuyuki Shigematsu, Rumiko Saito, Hiroaki Kanda, Yu Takahashi, Kengo Takeuchi, Shunji Takahashi, Kentaro Inamura · 2024 · Cancers
  8. Synergistic action of specialized metabolites from divergent biosynthesis in the human oral microbiome
    McKenna Loop Yao, Nicholas A. Zill, Colin Charles Barber, Yongle Du, Peijun Lin, Rui Zhai, Eunice Yoon, Dunya Al Marzooqi, Wenjun Zhang · 2025 · Proceedings of the National Academy of Sciences
  9. Chemotherapy modulation by a cancer-associated microbiota metabolite
    Daniel Martínez‐Martínez, Tanara Vieira Peres, Kristin Gehling, Leonor M. Quintaneiro, Cecilia Cabrera, Maksym Cherevatenko, Stephen J. Cutty, Lena Best, Γεώργιος Μαρίνος, Johannes Zimmerman et al. · 2025 · Cell Systems
  10. Meta-analysis reveals microbiome signatures for colorectal cancer that are universal across age groups and sequencing methods
    Selin Pekel, Nicolai Karcher, Morgan Essex, Fabian Springer, Stefano Romano, Quinten R. Ducarmon, Christian Schudoma, Martin Larralde, Alberto Lupatin, Sebastian Zeißig et al. · 2026 · Cell Host & Microbe
  11. Small Animals Gut Microbiome and Its Relationship with Cancer
    T. M. Ferrarias, Andreia Alexandra Ferreira Santos · 2021 · IntechOpen eBooks
  12. Gut microbiota and carcinogenesis in various human organs
    R. K. Kostin, D. A. Malyugin, Соленова Лия Геннадьевна, Elizaveta D. Kulaeva · 2023 · Journal of microbiology epidemiology immunobiology
  13. Study of Microbiota Associated to Early Tumors Can Shed Light on Colon Carcinogenesis
    Anna Aspesi, Marta La Vecchia, Gloria Sala, Emilia Ghelardi, Irma Dianzani · 2024 · International Journal of Molecular Sciences
  14. The power of microbes: the key role of gut microbiota in the initiation and progression of colorectal cancer
    Bo Ram Han, Yongfeng Zhang, Xue Feng, Jun J.J. Yang, Baolin Wang, Jiang Fang, Zhigang Wang, Jun Zhu, Ge Niu, Youxiang Guo · 2025 · Frontiers in Oncology
  15. Molecular messages in human microbiota
    Matthew T. Henke, Jon Clardy · 2019 · Science
  16. Applying Tobacco, Environmental, and Dietary-Related Biomarkers to Understand Cancer Etiology and Evaluate Prevention Strategies
    Lisa A. Peterson, Silvia Balbo, Naomi Fujioka, Dorothy K. Hatsukami, Stephen S. Hecht, Sharon E. Murphy, Irina S Stepanov, Natalia Y. Tretyakova, Robert J. Turesky, Peter W. Villalta · 2020 · Cancer Epidemiology Biomarkers & Prevention
  17. Escherichia coli-Derived γ-Lactams and Structurally Related Metabolites Are Produced at the Intersection of Colibactin and Fatty Acid Biosynthesis
    Chung Sub Kim, Tayah Turocy, Gyuri Moon, Emilee E. Shine, Jason M. Crawford · 2021 · Organic Letters
  18. Structure and function of prodrug-activating peptidases
    J. Velilla, Grace E. Kenney, Rachelle Gaudet · 2022 · Biochimie
  19. Targeted depletion of pks + bacteria from a fecal microbiota using specific antibodies
    Aitor Blanco‐Míguez, Raquel Marcos-Fernández, Lucía Guadamuro, Florentino Fdez‐Riverola, Joaquín Cubiella, Anália Maria Garcia Lourenço, Abelardo Margollés, Borja Sánchez · 2023 · mSystems
  20. A mutational signature that can be made by a bacterium arises in human colon cancer
    Ye Yang, Christian Jobin · 2020 · Nature
  21. Macrocyclic colibactins
    Seth B. Herzon · 2020 · Nature Chemistry
  22. Whole-Genome Sequencing of Invasive Neonatal Escherichia coli From Uppsala County, Sweden
    Anna Heydecke, Åsa Myrelid, Erik Normann, Karolina Gullsby, Eva Tano, Susanne Sütterlin · 2024 · The Journal of Infectious Diseases
  23. A cross-sectional survey study on the correlation analysis of nutritional status and intestinal flora in patients with esophageal cancer
    Liya Li, Zhang XinSheng, Huang Xiang, Zhao Liu, Lu Liu, Lv XiuMing, Ye Li, Jing Chen, Zhang KeMing, Wang HongChi et al. · 2024 · Frontiers in Nutrition
  24. Recent progress on drug delivery systems of regulating intratumoral bacteria for tumor therapy
    Jing Qi Feng, Yanhong Liu, Liming Gong, Chenfei Liu, Congcong Xiao, Liqing Chen, Mingji Jin, Zhonggao Gao, Wei Huang, Yubo Li · 2025 · Chinese Chemical Letters
  25. Host DNA damage and cellular fate in bacterial infections, with a focus on Staphylococcus aureus
    Nadia Berkova, Éric Guédon, Yves Le Loir, Michael J. Otto · 2025 · FEMS Microbiology Reviews
  26. RETRACTED: Understanding microbiota-driven oncogenesis: The role of metabolites in tumorigenesis
    Sadeeq Ullah, Chunyan Wu, Xiao Zou, Yangqing Zhong, Aftab Ahmad, Amin Ullah Jan, Yanguang Cong, Yong Chen, Lu Li · 2025 · iScience · Retracted
  27. Anna Karenina Principle, Immune‐Oncology‐Microbiome Trio and Cancer Microbiome Therapy
    Zhanshan Sam Ma · 2025 · WIREs Mechanisms of Disease
  28. Unlocking the Microbial Symphony: The Interplay of Human Microbiota in Cancer Immunotherapy Response
    Jessica Ann Chacon, Farah Faizuddin, Jack C. McKee, Aadil Sheikh, Victor M. Vasquez, Shrikanth S. Gadad, Ghislaine Mayer, Sharon Siby, Molly M. McCabe, Subramanian Dhandayuthapani · 2025 · Cancers
  29. Microbiota mechanisms in cancer progression and therapy
    Xing Zhang, Kyong Tkhe Fam, Tingting Dai, Howard C. Hang · 2025 · Cell chemical biology
  30. Thomasclavelia ramosa and alcohol-related hepatocellular carcinoma: a microbial culturomics study
    Reham Magdy Wasfy, Anissa Idrissa Abdoulaye, Patrick Borentain, Babacar Mbaye, Maryam Tidjani Alou, Aurélia Caputo, Claudia Andrieu, Giovanna Mottola, Anthony Levasseur, Matthieu Million et al. · 2025 · Gut Pathogens
  31. Structural study on human microbiome-derived polyketide synthases that assemble genotoxic colibactin
    Minjae Kim, Jinwoo Kim, Gyu Sung Lee, Paul Dominic B. Olinares, Yougant Airan, Jasmine L. Chow, Jongseok Park, Yujin Jeong, Jiho Park, Brian T. Chait et al. · 2025 · Structure
  32. Microbiome and the Hallmarks of Cancer
    Rachel M. Bleich, Janelle C. Arthur · 2021 · Physiology in health and disease
  33. Translational informatics for human microbiota: data resources, models and applications
    Ke Shen, Ahmad Ud Din, Baivab Sinha, Yi Zhou, Fuliang Qian, Bairong Shen · 2023 · Briefings in Bioinformatics
  34. Clostridioides difficile and colorectal cancer: a dangerous liaison
    Gabrio Bassotti, Fabrizio Stracci, Pierfrancesco Marconi, Katia Fettucciari · 2023 · European Journal of Gastroenterology & Hepatology
  35. Structure elucidation of colibactin
    Mengzhao Xue, Chung Sub Kim, Alan R. Healy, Kevin M. Wernke, Zhixun Wang, Madeline C. Frischling, Emilee E. Shine, Weiwei Wang, Seth B. Herzon, Jason M. Crawford · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  36. Heterologous Expression of a Cryptic BGC from Bilophila sp. Provides Access to a Novel Family of Antibacterial Thiazoles
    Maximilian Hohmann, Denis Iliasov, Martin F. Larralde, Widya U. Johannes, Klaus‐Peter Janssen, Georg Zeller, Thorsten Mascher, Tobias A. M. Gulder · 2025 · ACS Synthetic Biology
  37. The silent invaders: Biofilms in neurological, cardiovascular, and metabolic diseases
    Vinay Kumar, Anuradha Tyagi · 2025 · Life Sciences
  38. Early-Life Mutagenesis and the Rise of Early-Onset Colorectal Cancer
    Ludmil B. Alexandrov, Paul Brennan, Michael R. Stratton · 2026 · Cancer Discovery
  39. Interaction between Gut Microbiota and Dendritic Cells in Colorectal Cancer
    Kawther A. Zaher, Fatemah Salem Basingab · 2023 · Biomedicines
  40. Signalling and molecular pathways, overexpressed receptors of colorectal cancer and effective therapeutic targeting using biogenic silver nanoparticles
    Sandip Dey, Manik Ghosh, Abhimanyu Dev · 2024 · Gene
  41. The effects of pks + Escherichia coli and bile acid in colorectal tumorigenesis among people with cholelithiasis or cholecystectomy
    Si‐Yuan Pan, Cheng‐Bei Zhou, Jiawen Deng, Yi-Lu Zhou, Zhuhui Liu, Jing‐Yuan Fang · 2024 · Journal of Gastroenterology and Hepatology
  42. The application of organoids in cancers associated with pathogenic infections
    Yuyu Zhang, Tao Liu, Wenting He · 2024 · Clinical and Experimental Medicine
  43. Microbiota, mucosal immunity, and Colon cancer
    Julia L. Drewes, Jada C. Domingue, Franck Housseau · 2020 · Elsevier eBooks
  44. Escherichia coli Nissle 1917 secondary metabolism: aryl polyene biosynthesis and phosphopantetheinyl transferase crosstalk
    Courtney V. Jones, Brianna Jarboe, Haley M. Majer, Amy T. Ma, Joris Beld · 2021 · Applied Microbiology and Biotechnology
  45. Growth rate alterations of human colorectal cancer cells by 157 gut bacteria
    Rahwa Taddese, Daniel Rios Garza, Lilian N. Ruiter, Marien Isaäk de Jonge, Clara Belzer, Steven Aalvink, Irıs D. Nagtegaal, Bas E. Dutilh, Annemarie Boleij · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  46. Erratum for Wallenstein et al., “ClbR Is the Key Transcriptional Activator of Colibactin Gene Expression in Escherichia coli”
    Alexander Wallenstein, Nadine Rehm, Marina Brinkmann, Martina Selle, Nadège Bossuet‐Greif, Daniel Sauer, Boyke Bunk, Cathrin Spröer, Haleluya Tesfaye Wami, Stefan Homburg et al. · 2020 · mSphere
  47. Structural basis of Fusobacterium nucleatum adhesin Fap2 interaction with receptors on cancer and immune cells
    Felix Schöpf, Gian Luca Marongiu, Klaudia Milaj, Thiemo Sprink, Judith Kikhney, Annette Moter, Daniel Roderer · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  48. Emerging Understanding of Gut Microbiome in Colorectal Cancer and Food-Related Intervention Strategies
    Jie Zhang, Zhao‐Jun Wei, Guangsen Fan · 2025 · Foods
  49. Tissue-specific mutagenesis from endogenous guanine damage is suppressed by Polκ and DNA repair
    Yang Jiang, Moritz Jakob Przybilla, Linda V. Bakker, Foster C. Jacobs, Dylan Mckeon, Roxanne van der Sluijs, Koichi Sato, Juliëtte Wezenbeek, Joeri van Strien, Jeroen Willems et al. · 2025 · Nature Communications
  50. Induction of DNA Damage in Mouse Colorectum by Administration of Colibactin-producingEscherichia coli, Isolated from a Patient With Colorectal Cancer
    Takumi Narita, Yuta Tsunematsu, Noriyuki Miyoshi, Masami Komiya, Takahiro Hamoya, Gen Fujii, Yuko Yoshikawa, Michio Sato, Masanobu Kawanishi, Haruhiko Sugimura et al. · 2022 · In Vivo
  51. Cyclopropanol Warhead in Malleicyprol Confers Virulence of Human‐ and Animal‐Pathogenic Burkholderia Species
    Felix Trottmann, Jakob Franke, Ingrid Richter, Keishi Ishida, Michael Cyrulies, Hans‐Martin Dahse, Lars Regestein, Christian Hertweck · 2019 · Angewandte Chemie
  52. Gut microbiota and carcinogenesis: actual aspects
    Aleksandr F. Poveshchenko, V. N. Cherkas, А. В. Кабаков, Казаков Олег Васильевич · 2023 · Journal of microbiology epidemiology immunobiology
  53. Association between physical activity and the prevalence of tumorigenic bacteria in the gut microbiota of Japanese adults: a cross-sectional study
    Chiharu Iwasaka, Yuka Ninomiya, Takashi Nakagata, Hinako Nanri, Daiki Watanabe, Harumi Ohno, Kumpei Tanisawa, Kana Konishi, Haruka Murakami, Yuta Tsunematsu et al. · 2023 · Scientific Reports
  54. Gut Bacteria Provide Genetic and Molecular Reporter Systems to Identify Specific Diseases
    Leon M. T. Dicks · 2024 · International Journal of Molecular Sciences
  55. Colibactin Exerts Androgen-dependent and -independent Effects on Prostate Cancer
    Raag Agrawal, Sarah M. Al-Hiyari, Rupert Hugh-White, Robert Hromas, Yash Patel, Elizabeth A. Williamson, Mohammed Faizal Eeman Mootor, Alfredo Gonzalez, Jianmin Fu, Roni Haas et al. · 2024 · European Urology Oncology
  56. Structure-Based Modeling of the Gut Bacteria–Host Interactome Through Statistical Analysis of Domain–Domain Associations Using Machine Learning
    Despoina P. Kiouri, Georgios Batsis, Thomas Mavromoustakos, Alessandro Giuliani, Christos T. Chasapis · 2025 · BioTech
  57. Molecular Mechanisms of Gut Microbiota-Associated Colorectal Carcinogenesis
    Yichang Shao, Xun Zeng · 2020 · Infectious Microbes & Diseases
  58. Inflammation and cancer
    Gerardo Guillermo Mackenzie · 2021 · Elsevier eBooks
  59. Which bacterial toxins are worthy of validation as markers in colorectal cancer screening? A critical review
    Kristýna Mezerová, Vladislav Raclavský, Lubomír Starý · 2021 · Biomedical Papers
  60. The mysteries of macrocyclic colibactins
    Erik S. Carlson, Emily P. Balskus · 2019 · Nature Chemistry
  61. Implications of Lateral or Horizontal Gene Transfer from Bacteria to the Human Gastrointestinal System for Cancer Development and Treatment
    Ana G. Abril, P. G. Lanzi, Vicente Notario · 2019 · Springer eBooks
  62. Polyketide synthase positive Escherichia coli one‐time measurement in stool is not informative of colorectal cancer risk in a screening setting
    Willemijn de Klaver, Meike de Wit, Anne S. Bolijn, Marianne Tijssen, Pien Delis‐van Diemen, Margriet Lemmens, Manon C.W. Spaander, Evelien Dekker, Monique Esther van Leerdam, Veerle M.H. Coupé et al. · 2024 · The Journal of Pathology
  63. Harnessing the gut microbiome to enhance cancer immunotherapy: Current advances and future directions in microbiota‐based therapeutic strategies
    Binyan Zhao, Bailing Zhou, Qing Li, Chunyan Su, Jing Ma, Li Yang · 2024 · MedComm – Future Medicine
  64. Combatting virulent gut bacteria by inhibiting the biosynthesis of a two-component lanthipeptide toxin
    Ryan Moreira, Bidisha Chakraborty, Yi Yang, Chandrashekhar Padhi, Michael S. Gilmore, Satish K. Nair, Wilfred A. van der Donk · 2025 · Nature Communications
  65. Gut microbiota and chemoradiotherapy response in rectal cancer: Biomarker opportunities
    Christophe Taoum, A. Devaux, Philippe Rouanet, Pierre‐Emmanuel Colombo, Delphine Boucher, Mathilde Bonnet · 2025 · Critical Reviews in Oncology/Hematology
  66. Synergistic Interactions Between Gut and Intratumoral Microbiota: A New Perspective on the Oncogenesis and Treatment of Colorectal Cancer
    Qi Wang, Hao Ding · 2025 · Digestive Diseases and Sciences
  67. Mutanobactin D from the Human Microbiome: Chemistry, Biology, and Molecular Dynamics Studies
    Patricia Brandl, Lukas Lüthy, Felix Pultar, Moritz E. Hansen, Nicola Jelmini, Justin Faris, Samuel O. Yasmin, Anna Sophia Kamenik, René Arnold, Marc‐Olivier Ebert et al. · 2025 · Journal of the American Chemical Society
  68. From biomarker to clinical utility: translating the advanced lung cancer inflammation index into a machine learning-driven risk stratification tool for colorectal cancer
    Ming Gao, Ying Li, Huimei Wang, Jinming Zhang, Guangxun Zhang, Nan Zhang · 2025 · Journal of Translational Medicine
  69. Intratumoral microbiome and pancreatic cancer: an enabling hallmark and path to novel treatments?
    Malte Carstensen, Lisa-Marie Philipp, Meghna Basu, Patrick Hoffmann, Jan-Niklas Klenig, Anna Maxi Wandmacher, Susanne Sebens · 2025 · British Journal of Cancer
  70. Intratumoral microbiota: synergistic reshaping of lung cancer microenvironment via inflammation and immunity
    Ruilin Zhang, Zhao Li, Xingfei Liu, Zhengzhou Qiu, Yifan Li, Chenggen Gao, Changying Guo · 2026 · Frontiers in Immunology
  71. Roles of the gut microbiota in cancer immunotherapy: Mechanistic foundations and therapeutic opportunities
    Qinglin Wu, Yi-Ran Zhou, Zi-rong Chen, Ming-Xin Liu, Meng-Xin Liu, Yi-Fei Liu, Zhishu Li, Qi-Rui Zhao, Yong-Qian Zhang, H. Zhang et al. · 2026 · Critical Reviews in Oncology/Hematology
  72. Strain Diversity in the Human Microbiome: Personal Variation, Pathobionts, Therapeutics, and Methodological Challenges
    Hyunjoon Park, Jung Soo Kim, Dong Joon Kim, Ki Tae Suk · 2026 · Microorganisms
  73. Chemiluminescent Probes Allow for the Rapid Identification of Colibactin-Producing Bacteria
    Miguel A. Aguilar Ramos, Sara Gutkin, Maya David, Doron Shabat, Emily P. Balskus · 2026 · JACS Au
  74. From Microbial Ecology to Functional Components in Microbe–Host Interactions
    T Wang, Zhengjin Wang, Xiao Yang, Lei Zhang · 2026 · Biology
  75. Gut microbiota and metabolic control of immune checkpoint blockade in cancer
    Joseph L. Gladstone, Gregory F. Sonnenberg · 2026 · Cell Metabolism
  76. Gut microbiota in health and disease
    Y N Li, Xueyan Xiao, Xin Jiang, Xinyi Li, W WANG, Rong Lin · 2026 · Molecular Biomedicine
  77. New Relevant Evidence in Cholangiocarcinoma Biology and Characterization
    Nunzia Porro, Elena Spínola-Lasso, Mirella Pastore, Alessandra Caligiuri, Luca Di Tommaso, Fabio Marra, Alessandra Gentilini · 2024 · Cancers
  78. Metaproteomics of human microbiota: Progress and key challenges for precision medicine
    Yu‐Qi Feng, Dongbo Liu, Yongheng Chen, Wei Zhang, Yijing He · 2025 · Process Biochemistry
  79. Intratumoral microbiota: a new perspective in cancer initiation, development, and therapy
    Huiling Liu, Zhonghui Katie Luo, Fangzhen Luo, Xilian Wang, Hua Wei, Cui‐Yun Yu · 2025 · RSC Pharmaceutics
  80. Natural products influence bacteriophage infectivity
    Zhiyu Zang, Joseph P. Gerdt · 2025 · Natural Product Reports
  81. TNF-shaped microbiota promotes cancer
    Giorgio Trinchieri · 2020 · Nature Cancer
  82. Antibacterials
    Ana V. Cheng, William M. Wuest · 2020 · ACS in focus
  83. Gut microbiota: key facilitator in metastasis of colorectal cancer
    Siyi Yu, Shuyi Wang, Bin Xiong, Chun‐Wei Peng · 2023 · Frontiers in Oncology
  84. Total synthesis of (±)-3-thiaglutamate
    Hao Chen, Sohjeong Kim, Chi P. Ting · 2024 · Tetrahedron Letters
  85. Global biogeography and projection of antimicrobial toxin genes
    Ya Liu, Yu Geng, Yiru Jiang, Jingyu Sun, Jing Li, Yue‐zhong Li, Zheng Zhang · 2025 · Microbiome
  86. Biosynthesis of Gut‐Microbiota‐Derived Lantibiotics Reveals a Subgroup of S8 Family Proteases for Class III Leader Removal
    Yingying Zhang, Zhilai Hong, Liang Zhou, Zhenkun Zhang, Ting Tang, Erpeng Guo, Jie Zheng, Ciji Wang, Lei Dai, Tong Si et al. · 2021 · Angewandte Chemie
  87. The covalent reactivity of functionalized 5-hydroxy-butyrolactams is the basis for targeting of fatty acid binding protein 5 (FABP5) by the neurotrophic agent MT-21
    Esben B. Svenningsen, Rasmus N. Ottosen, Katrine Bruun Jørgensen, Marija Nišavić, Camilla K. Larsen, Bente K. Hansen, Yong Wang, Kresten Lindorff‐Larsen, Thomas Tørring, Stephan M. Hacker et al. · 2022 · RSC Chemical Biology
  88. Reply to Dubbert and von Bünau, “A Probiotic Friend”
    Jean‐Philippe Nougayrède, Éric Oswald · 2021 · mSphere
  89. The gut bacterial natural product colibactin triggers induction of latent viruses in diverse bacteria
    Justin E. Silpe, Joel W. H. Wong, Siân V. Owen, Michael Baym, Emily P. Balskus · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  90. Colorectal cancer and gut microbiota
    I.A. Ereemeeva, Дарья Валерьевна Багдасарова, Елена Владимировна Артёмова, Коломейцева Алина Андреевна, А. А. Феденко · 2024 · P A Herzen Journal of Oncology
  91. The Prevalence of Polyketide Synthase-Positive E. coli in Cystic Fibrosis
    Christopher Chan, Michael Jonathon Coffey, Caitlin Murphy, Isabelle R. McKay, Jumaana Abdu, Keerti Paida, Rachel Y. Tam, Hannah Wrigley-Carr, Bernadette J. Prentice, Louisa Owens et al. · 2025 · Microorganisms
  92. A possible role of urinary genotoxic Escherichia coli in prostate cancer in Nigerian patients
    Sharon O. Akinpelu, Grace Iyabo Olasehinde, Olayemi Oluseun Akinnola · 2025 · BMC Research Notes
  93. Colorectal cancer prognosis: insights from the tumor immune microenvironment and gut microbiota
    Quan Chen, Youtao Zhou, Zikai Lin, Cuiyan Yang, Hui Chen, Chuanfeng Ke · 2025 · Journal of Gastrointestinal Oncology
  94. Effect of immune-related intratumoral microbiota and host gene expression on cancer prognosis
    Qingzhen Fu, Ning Zhao, Xia Li, Yanbing Li, Tian Tian, Lijing Gao, Yukun Cao, Liwan Wang, Jinyin Liu, Fan Wang et al. · 2025 · mSystems
  95. The Potential Anticancer Mechanisms of Probiotics: A Comprehensive Review
    Chao Tang, Yue Qian, Shiyao Jia, Junyan Zhang, Yao Zhang, Yuting Ren, Huimin Yong, Jingguo Xu, Juan Kan, Jun Liu · 2025 · Probiotics and Antimicrobial Proteins
  96. Molecular basis of DNA cross-linking by bacteria
    Orlando D. Schärer · 2025 · Science
  97. Protecting Group Strategies in Natural Product Biosynthesis
    Akimasa Miyanaga, Yohei Katsuyama · 2026 · Journal of Natural Products
  98. The biosynthetic gene cluster landscape of the oral microbiome across health and dental caries
    McKenna Loop Yao, Peijun Lin, Kailey Hua, Wenjun Zhang · 2026 · Journal of Industrial Microbiology & Biotechnology
  99. Advanced computational analysis in metagenomic studies to support precision medicine
    Gianmarco Piccinno, Francesco Asnicar · 2026 · Clinical Microbiology and Infection
  100. The Gut-Prostate Axis: Decoding the Interplay of Environmental Factors, Microbial Metabolites, and Hormonal Regulation in Prostate Cancer Pathogenesis
    Gopu Sandeep, Srijoni Pahari, Vinayak Nayak, Rohit Gundamaraju, Parul Mishra, Ashish Misra · 2026 · Technology in Cancer Research & Treatment